The pharmacology of dextran and the physiological background for the clinical use of rheomacrodex and macrodex.
D001783:Blood Flow Velocity; D001809:Blood Viscosity / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D003102:Colloids; D003911:Dextrans / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology*; D004903:Erythrocyte Aggregation / Q000188:drug therapy*; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D006400:Hematocrit; D006801:Humans; D000960:Hypolipidemic Agents / Q000494:pharmacology; D008970:Molecular Weight; D009995:Osmosis; D009997:Osmotic Pressure; D010953:Plasma Volume
D003102:Colloids; D003911:Dextrans; D005343:Fibrinolytic Agents; D000960:Hypolipidemic Agents